Bio-Thera Solutions and SteinCares Add Another Biosimilar, Expanding their Alliance Active Ingredient: N/A Date: Dec 16, 2024 Product: N/A Reference Product: N/A Company: Bio-Thera Solutions & SteinCares Disease: N/A Shots: 6. The US FDA Grants Approval to Celltrion's Steqeyma (Biosimilar, Stelara) Active Ingredient: Ustekinumab Date: Dec 16, 2024 Product: Steqeyma Reference Product: Stelara Company: Celltrion Disease: Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease & Ulcerative Colitis Shots: 7. Dong-A ST Receives EC Approval for Imuldosa (Biosimilar, Stelara) Active Ingredient: Ustekinumab Date: Dec 19, 2024 Product: Imuldosa Reference Product: Stelara Company: Dong-A ST Disease: Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease & Ulcerative Colitis Shots: 8.